saged

Designed for doctors, this course explores a range of health conditions that disproportionately affect people assigned female at birth and intersex individuals with female reproductive organs—many of which are historically under-recognised and undertreated. These conditions can significantly impact physical, mental, and reproductive health, often requiring nuanced, multidisciplinary approaches. With medical cannabis emerging as a potential adjunct for symptom management, this course provides evidence-based insights into its role across conditions including: Endometriosis Dysmenorrhoea Polycystic Ovary Syndrome (PCOS) Premenstrual Dysphoric Disorder (PMDD) Postpartum Depression (PPD) Breast, ovarian, and uterine cancers Perimenopause and menopause The course also addresses key safety considerations, including contraindications during pregnancy and lactation. Clinicians will leave with a deeper understanding of how to safely integrate medical cannabis into patient-centred care plans alongside conventional therapies. Preview this course by watching the video above. Estimated Duration: 5.5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe and explain the causes, symptoms, effects, and risk factors for various reproductive health conditions, including perimenopause, menopause, breast, ovarian, and uterine cancers, dysmenorrhoea, endometriosis, polycystic ovarian syndrome (PCOS), premenstrual dysphoric disorder (PMDD), and postpartum depression (PPD) Identify and evaluate common conventional treatment options for these conditions and their potential drawbacks Discuss the therapeutic potential of medical cannabis for treating symptoms of these reproductive health conditions Identify considerations for selecting suitable medical cannabis products for treating symptoms related to these conditions Identify TGA guidelines on contraindications for medical cannabis use during pregnancy and chest-feeding Discuss potential short and long-term risks of early cannabis exposure Explain the role of the endocannabinoid system in reproductive function Describe the risks of cannabis use during pregnancy, planning to become pregnant, and postnatal phases for both the foetus or infant and the birth-giver

Designed for nurses, this course delves into a range of conditions that are uniquely prevalent among people assigned female at birth and intersex individuals with female reproductive organs. These conditions often go under-recognised and can profoundly affect health and quality of life. Conventional treatments sometimes fail to fully address these issues and can carry significant risks. With medical cannabis emerging as a promising alternative, this course offers evidence-based insights into its potential for managing symptoms of: Endometriosis Dysmenorrhoea Polycystic Ovary Syndrome (PCOS) Premenstrual Dysphoric Disorder (PMDD) Postpartum Depression (PPD) Breast, ovarian, and uterine cancers Perimenopause and menopause Additionally, it covers critical pregnancy-related contraindications for medical cannabis. Healthcare professionals will gain crucial knowledge and skills to expand their therapeutic toolkit, integrating both traditional and cannabis-based approaches to enhance patient outcomes. This is an opportunity to stay at the forefront of medical advancements and provide innovative care options for your patients. Preview this course by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Assess medical cannabis’ therapeutic potential for treating symptoms of dysmenorrhoea, endometriosis, PCOS, PMDD, PPD, menopause, and breast, ovarian and uterine cancers considering its pharmacological interaction with the condition’s pathophysiology and efficacy, and drawbacks of current recommended treatments Identify characteristics of suitable medical cannabis strains, compounds, product types and administration methods for treating symptoms of the particular condition affecting IAFABP Identify and explain pregnancy-related contraindications for using medical cannabis

Designed for pharmacists, this course delves into a range of conditions that are uniquely prevalent among people assigned female at birth and intersex individuals with female reproductive organs. These conditions often go under-recognised and can profoundly affect health and quality of life. Conventional treatments sometimes fail to fully address these issues and can carry significant risks. With medical cannabis emerging as a promising alternative, this course offers evidence-based insights into its potential for managing symptoms of: Endometriosis Dysmenorrhoea Polycystic Ovary Syndrome (PCOS) Premenstrual Dysphoric Disorder (PMDD) Postpartum Depression (PPD) Breast, ovarian, and uterine cancers Perimenopause and menopause Additionally, it covers critical pregnancy-related contraindications for medical cannabis. Healthcare professionals will gain crucial knowledge and skills to expand their therapeutic toolkit, integrating both traditional and cannabis-based approaches to enhance patient outcomes. This is an opportunity to stay at the forefront of medical advancements and provide innovative care options for your patients. Preview this course by watching the video above. Estimated Duration: 4 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Assess when and how medical cannabis may improve treatment outcomes for IAFABP Make informed recommendations to patients and their doctors around medical cannabis as a treatment option Deliver exceptional patient-centred care by understanding your patients' experiences and exploring their options, you will be equipped to offer compassionate, professional and attentive care when your patients ask questions or come to dispense their medications

This microcredential offers healthcare professionals an in-depth look at how medical cannabis can be integrated into the management of chronic pain in complex patient cases. Through real-world scenarios, this microcredential highlights the therapeutic potential of cannabis while addressing concerns related to coexisting conditions, medication interactions, and patient quality of life. This microcredential includes: Clinical Case Study - ADHD Symptoms and Chronic Pain: Explore how medical cannabis helped Hayley, a 37-year-old patient with combined-type ADHD and chronic pain, manage her attention, anxiety, sleep, and physical discomfort. Clinical Case Study - Chronic Pain & Hepatic Dysfunction: Follow Stephen, a 56-year-old with hepatic fibrosis, as his healthcare team safely incorporated medical cannabis into his treatment plan for chronic back pain and gout, restoring his active lifestyle. Clinical Case Study - Chronic Pain, Insomnia & Cardiac Issues: Delve into Jen’s case, a 60-year-old with complex regional pain syndrome and stable cardiovascular disease, who found relief from chronic pain and insomnia through carefully managed medical cannabis treatment. Clinical Case Study - MS-Associated Chronic Pain and Spasticity: Examine how Johanna, a 39-year-old with multiple sclerosis, addressed her neuropathic pain and spasticity using an affordable, well-balanced cannabis treatment plan, overcoming challenges related to her other medications and financial constraints. This microcredential is designed to enhance practitioners’ understanding of medical cannabis' role in improving patient outcomes in chronic pain management, even in complex clinical scenarios. Preview this module by watching the video above. Estimated Duration: 4 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Demonstrate an understanding of the role of medical cannabis in managing chronic pain in patients with coexisting conditions like ADHD, hepatic dysfunction, cardiac issues, and multiple sclerosis. Evaluate real-world case studies to assess cannabis' therapeutic potential for symptom management. Apply critical safety considerations and risk mitigation strategies for patients with hepatic and cardiac concerns. Discuss potential drug-drug interactions and the safe use of medical cannabis in complex patient cases. Facilitate patient-centered discussions around medical cannabis for chronic pain, addressing sleep and psychological symptoms. Devise tailored cannabis treatment plans that consider patient safety, minimise risk, and enhance quality of life in complex cases.

This course is designed to equip pharmacist professionals with the knowledge and skills necessary to navigate Australia's evolving medical cannabis landscape. Designed for pharmacists, this course will help you gain essential knowledge for safely and effectively handling medical cannabis. Develop a practical understanding of the endocannabinoid system, crucial for dispensing, monitoring, and adjusting cannabinoid medications within Australia's regulations. Understand your distinct role as a pharmacist in patient care, and learn to lead discussions with your patients for their best health outcomes. Join a cohort of passionate pharmacists in Australia who have chosen to broaden their skills in medical cannabis prescribing. With this course, you can be part of improving treatment options for patients suffering from chronic conditions Australia wide.  Preview this course by watching the video above. Estimated Duration: 8 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Discuss the individual components of the cannabis plant Describe cannabis medicine options accurately Explain how the endocannabinoid system functions Assess the suitability of cannabis treatment for various chronic disease states Identify appropriate and inappropriate patient cohorts for medical cannabis treatment Discuss with patients about medical cannabis as a therapeutic option for symptom management Describe how to initiate, monitor and titrate cannabinoid medicines Apply critical safety considerations in patient-centred care Describe the role and responsibilities of pharmacists in relation to medical cannabis therapy Explain how pharmacists can educate patients on safe and effective use of medical cannabis Discuss how to collaborate with other healthcare providers to monitor patient outcomes and adjust treatment plans Describe requirements for storing medical cannabis Discuss quality control measures for medical cannabis products Explain the Australian regulatory frameworks surrounding medical cannabis provision Claim 17 CPD credits for eligible participants.

This course is designed to equip nursing professionals with the knowledge and skills necessary to navigate Australia's evolving medical cannabis landscape. DEVELOPER'S NOTE: As nurses, we understand the growing importance of holistic care and the role medical cannabis can have in managing a multitude of conditions. Join us in this meticulously crafted course to explore the history and botany of cannabis, understand the role of the endocannabinoid system and homeostasis. Learn how to navigate TGA processes, monitor and manage potential adverse side effects and other important aspects of cannabis treatment and patient care. This course is created and endorsed by nurses who believe in the potential of medical cannabis as a vital component of integrative, modern healthcare. Preview this course by watching the video above. Estimated Duration: 5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe cannabis medicines accurately and demonstrate an understanding of the individual chemical components of the plant. Demonstrate an understanding of endocannabinoid system function. Assess the suitability of cannabis treatments in various chronic disease states. Identify appropriate patient cohorts for medical cannabis treatment. Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management. Monitor and provide titration advice around cannabinoid medicines.  Apply critical safety considerations in patient centred care. Navigate the regulatory frameworks surrounding medical cannabis provision in Australia.  Claim 5 CPD hours for eligible participants.

This accredited course provides doctors with a comprehensive introduction to the clinical and regulatory foundations of medical cannabis prescribing in Australia. As patient interest in cannabinoid-based therapies increases, it is essential for prescribers to be equipped with evidence-informed knowledge and practical skills to navigate this evolving space safely and effectively. Through this program, participants will explore the endocannabinoid system and its relevance to human physiology, examine the pharmacology of key cannabis constituents, and gain practical insight into initiating, monitoring, and titrating medical cannabis products. The course also addresses the Australian regulatory landscape and offers guidance on assessing patient suitability, facilitating informed discussions, and applying critical safety considerations in clinical practice. Designed to support evidence-based decision-making, this course empowers doctors to responsibly consider medical cannabis as part of a broader, patient-centred approach to managing chronic symptoms and conditions. Preview this course by watching the video above. Estimated Duration: 5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe cannabis medicines accurately and demonstrate an understanding of the individual chemical components of the plant. Demonstrate an understanding of endocannabinoid system function. Assess the suitability of cannabis treatments in various chronic disease states. Identify appropriate patient cohorts for medical cannabis treatment. Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management. Initiate, monitor and titrate cannabinoid medicines.  Apply critical safety considerations in patient-centred care. Navigate the regulatory frameworks surrounding medical cannabis provision in Australia. 

Palliative care focusses on relieving suffering and improving quality of life for individuals with life-limiting illnesses. Historically, practitioners applied palliative care only to cancer patients, but it's increasingly being introduced earlier in the course of illness.¹ This module examines the role of palliative care as part of person-centred health services, aligned with the World Health Organisation's framework, which highlights the importance of meeting individual needs and preferences.² Learners will explore challenges such as symptom management and the complexities of polypharmacy, which can limit the effectiveness of traditional treatments. The module also discusses the potential role of medical cannabis in addressing symptoms, reducing medication side effects, and improving quality of life for patients in palliative care. This module provides healthcare practitioners with knowledge to responsibly integrate medical cannabis into palliative care plans. Preview this module by watching the video above. Estimated Duration: 1 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Define palliative care Discuss the purposes and standard processes and approaches in palliative care Discuss the importance of goals of care in palliative care Discuss the role of services, supports and people involved in palliative care Explain how palliative care differs from end-of-life care Explain how the endocannabinoid system may influence symptoms and side effects experienced by those in palliative care Explain how health practitioners and professionals may facilitate medical cannabis treatment to manage symptoms and side effects commonly experienced by those in palliative care Identify clinical considerations that relate to medical cannabis use in palliative care References ¹ Lukas Radbruch, et al. “Redefining Palliative Care—a New Consensus-Based Definition.” Journal of Pain and Symptom Management, vol. 60, no. 4, 6 May 2020, pp. 754–764, www.sciencedirect.com/science/article/pii/S0885392420302475, https://doi.org/10.1016/j.jpainsymman.2020.04.027. Accessed 17 Oct. 2024.² Australian Institute of Health and Welfare. “Palliative Care Services in Australia, Summary - Australian Institute of Health and Welfare.” Australian Institute of Health and Welfare, 2023, www.aihw.gov.au/reports/palliative-care-services/palliative-care-services-in-australia/contents/summary. Accessed 23 Oct. 2024.

This microcredential offers healthcare professionals a comprehensive overview of medical cannabis, its pharmacological properties, and treatment options. Through a series of focussed modules, learners will gain a deep understanding of how cannabis interacts with the endocannabinoid system and its therapeutic potential.Modules Include: The Endocannabinoid System and Medical Cannabis – An Introduction Explore the foundational science behind medical cannabis and its interaction with the human body's endocannabinoid system. Understand key mechanisms of action that make cannabis a unique treatment option. Medical Cannabis Taxonomy, Genetics, Strains, and Compounds Delve into the biological diversity of cannabis. Learn about the taxonomy, genetics, and various strains, and examine the wide range of cannabinoids and terpenes that influence its therapeutic effects. Introduction to Medical Cannabis Products Gain an essential overview of medical cannabis products, covering their categorisation, administration methods, and key components like THC and CBD, including factors influencing the safety and efficacy of medical cannabis products, such as speed of onset, bioavailability, and duration of effects. Preview this module by watching the video above. Estimated Duration: 3 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this microcredential, you’ll be able to: Describe the discoveries that shaped today's understanding of the endocannabinoid system (ECS) Explain the functions of the ECS, its main components, and how they interact Discuss the function and benefits of retrograde cell signalling Outline the roles and functions of cannabinoid receptors CB1 and CB2, and vanilloid receptor TRPV1 Identify ECS ligands and non-ligand mediators and describe their role in ECS function Define endocannabinoid tone and its influencing factors Discuss clinical considerations related to the ECS Identify cannabis' taxonomic status Identify and discuss key components of strains and chemovars Identify key compounds in medical cannabis and explain their potential interactions and effects within the body Describe the factors that impact medical cannabis' effects within the body Explain how practitioners may adjust medical cannabis treatment to account for clinical and individual factors, risks and contraindications Define endogenous and exogenous cannabinoids Describe the properties of THC and CBD, including their potential therapeutic and medicinal effects Describe different medical cannabis product categorisations Identify, for different administration methods, speed of onset, bioavailability and duration of effects Explain considerations when selecting medical cannabis products to improve safety and efficacy for patients

This module provides healthcare practitioners with a comprehensive understanding of the biological components of medical cannabis and their therapeutic potential. As cannabis becomes more widely accepted, it's essential to grasp how its taxonomy, strains, chemovars, and key compounds interact within the body to provide treatment benefits. Through this module, practitioners will learn how to identify cannabis' taxonomic status, discuss the key components of strains, and explain how cannabinoids and terpenes affect the body. You'll also explore the factors that influence cannabis' effects and how practitioners can adjust treatment to account for clinical and individual patient factors, risks, and contraindications. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Identify cannabis' taxonomic status Identify and discuss key components of strains and chemovars Identify key compounds in medical cannabis and explain their potential interactions and effects within the body Describe the factors that impact medical cannabis' effects within the body Explain how practitioners may adjust medical cannabis treatment to account for clinical and individual factors, risks and contraindications

Terpenes are plant-based compounds responsible for a plant's aroma,¹ likely contributing to pigmentation and offering protection against environmental threats, such as predators or adverse weather conditions.² They may also provide therapeutic effects when ingested or applied topically, although in some cases, they can cause side effects.¹ While research on terpenes is still in its early stages, some studies suggest they may influence and enhance mood, potentially through interactions with body systems like the endocannabinoid system.³ Cannabis plants are particularly rich in terpenes, with over 150 types identified across various cannabis cultivars.⁴ Emerging evidence also indicates that terpenes might interact with other compounds, such as cannabinoids and additional terpenes, to produce synergistic or cumulative effects.⁵ However, this area of study remains in its infancy.⁶ These findings highlight the diverse therapeutic potential of medical cannabis cultivars, shaped by their unique compound profiles and effects.⁶ A deeper understanding of terpenes' therapeutic potential can help health practitioners make informed clinical decisions, tailored to each patient's individual needs, preferences, and overall well-being. Preview this module by watching the video above. Estimated Duration: 1 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Define terpene Explain terpenes' functions in plants Discuss terpenes' hypothesised general functions in the body and potential interactions with other compounds Define terpenoid Explain the difference between terpenes and terpenoids Identify and describe characteristics of key terpenoid subclasses Explain the relevance of target boiling points for terpenes and terpenoids during medical cannabis administration Identify and describe key terpenes' and terpenoids' characteristics, mechanisms of action, therapeutic potential and target boiling point Identify current gaps in research and their implications for the clinical use of terpenes and terpenoids References: Paduch, Roman, et al. “Terpenes: Substances Useful in Human Healthcare.” Archivum Immunologiae et Therapiae Experimentalis, vol. 55, no. 5, Oct. 2007, pp. 315–327, https://doi.org/10.1007/s00005-007-0039-1. Yang, Jianming, et al. “Enhancing Production of Bio-Isoprene Using Hybrid MVA Pathway and Isoprene Synthase in E. Coli.” PLoS ONE, vol. 7, no. 4, 27 Apr. 2012, p. e33509, https://doi.org/10.1371/journal.pone.0033509. Christensen, Catalina, et al. “Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t.” Biomedicines, vol. 11, no. 8, 21 Aug. 2023, pp. 2323–2323, https://doi.org/10.3390/biomedicines11082323. Booth, Judith K., and Jörg Bohlmann. “Terpenes in Cannabis Sativa – from Plant Genome to Humans.” Plant Science, vol. 284, July 2019, pp. 67–72, https://doi.org/10.1016/j.plantsci.2019.03.022. LaVigne, Justin E., et al. “Cannabis Sativa Terpenes Are Cannabimimetic and Selectively Enhance Cannabinoid Activity.” Scientific Reports, vol. 11, no. 1, 15 Apr. 2021, https://doi.org/10.1038/s41598-021-87740-8. Sommano, Sarana Rose, et al. “The Cannabis Terpenes.” Molecules, vol. 25, no. 24, 1 Jan. 2020, p. 5792, www.mdpi.com/1420-3049/25/24/5792, https://doi.org/10.3390/molecules25245792.

This module explores the complexities of cancer, including its pathogenesis, common types, grading criteria, and contemporary treatment options. Learners will gain insights into the rising incidence of cancer in Australia and the significant advancements in survival rates, alongside the challenges posed by treatment side effects. A key focus will be the emerging role of medical cannabis, examining its therapeutic potential for alleviating cancer symptoms and mitigating treatment side effects, as well as its implications for palliative care. By the end of the module, learners will be equipped to explain cancer's biological mechanisms, identify various cancers and their treatments, and assess the benefits and risks of medical cannabis in cancer care. This knowledge aims to enhance understanding and support improved patient outcomes in the evolving landscape of cancer treatment. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathogenesis and pathophysiology of cancer Identify and describe the main types of cancers and tumours Identify and describe the common cancer-grading criteria Identify and explain contemporary cancer treatments, their benefits, risks and side effects Explain medical cannabis’ therapeutic potential for treating cancer symptoms and treatment side effects Identify risks associated with medical cannabis treatment for those with cancer Explain how medical cannabis may play a role in palliative care for those with cancer